Latest Regulatory Progress News

BPM Minerals has secured the Forelands Gold Project with promising high-grade intercepts and divested its Claw Gold Project to Capricorn Metals, bolstering its cash position ahead of upcoming drilling.

Orthocell has boosted its investment in Marine Biomedical to secure exclusive global distribution rights for PearlBone™, an innovative bone substitute nearing FDA approval, enhancing its regenerative medicine portfolio.

PainChek Limited has appointed Sasha Grant as Head of Growth for its AI-powered Infant App, aiming to scale its presence in a $15 billion global market. Early Australian adoption shows promising conversion rates as the company prepares for international expansion.

Ark Mines has secured Environmental Authority approval for its Sandy Mitchell Rare Earths project in Queensland, marking a crucial step towards obtaining its Mining Licence. The company has also completed a major drilling program, setting the stage for an upcoming Pre-Feasibility Study.

PolyNovo Limited has appointed Bruce Peatey as its new CEO, bringing extensive international healthcare experience to drive the company’s next growth phase. Peatey’s leadership is expected to accelerate PolyNovo’s expansion into new markets and outpatient care.

EVE Health Group Limited has launched a $1.1 million capital raising via a placement to fund the commercial rollout of its two pharmaceutical products, Dyspro and Libbo. The offer includes shares and options, with some subject to shareholder approval.

VHM Limited has significantly expanded its Exploration Target at the Goschen Project in Victoria, revealing a potential resource of up to 4 billion tonnes of ore rich in valuable heavy minerals and rare earths. This update underscores Goschen's emerging status as a major player in Australia's mineral sands sector.

29Metals reports a steady copper output but significant zinc production decline due to seismic disruptions at Golden Grove, alongside rising operational costs and ongoing progress at Capricorn Copper.

3D Energi has raised $9.4 million to fund the drilling of its Essington-1 well in the Otway Basin, with Korea National Oil Corporation acquiring a 29% stake in the joint venture alongside ConocoPhillips. Drilling is set to commence in late October 2025.

Medical Developments International reported a strong start to FY26 with significant revenue growth driven by increased Penthrox volumes and pricing improvements in Australia, alongside steady European demand and progress on paediatric label approvals.

EVE Health Group has raised $1.1 million to accelerate the commercial rollout of its innovative pharmaceutical products Dyspro and Libbo, signaling strong investor confidence in its growth strategy.

Greenwing Resources has unveiled a scoping study for its Que River polymetallic project in Tasmania, outlining a low capital expenditure route to potentially generate A$63 million in cash flow within a year. The study leverages existing infrastructure and highlights significant exploration upside beneath existing pits.